Product Images Afstyla Antihemophilic Factor (recombinant), Single Chain
View Photos of Packaging, Labels & Appearance
- Fig. 1 - afstyla 01
- Fig. 2 - afstyla 02
- Fig. 3 - afstyla 03
- Fig. 4 - afstyla 04
- Fig. 5 - afstyla 05
- Fig. 6 - afstyla 06
- Fig. 7 - afstyla 07
- Fig. 8 - afstyla 08
- Fig. 1 - afstyla 09
- Fig. 2 - afstyla 10
- Fig. 3 - afstyla 11
- Fig. 4 - afstyla 12
- Fig. 5 - afstyla 13
- Fig. 6 - afstyla 14
- Fig. 7 - afstyla 15
- Fig. 8 - afstyla 16
- PRINCIPAL DISPLAY PANEL - Kit Carton - 250 IU - afstyla 17
- PRINCIPAL DISPLAY PANEL - Kit Carton - 500 IU - afstyla 18
- PRINCIPAL DISPLAY PANEL - Kit Carton - 1000 IU - afstyla 19
- PRINCIPAL DISPLAY PANEL - Kit Carton - 2000 IU - afstyla 20
- PRINCIPAL DISPLAY PANEL - Kit Carton - 3000 IU - afstyla 21
- PRINCIPAL DISPLAY PANEL - Kit Carton - 1500 IU - afstyla 22
- PRINCIPAL DISPLAY PANEL - Kit Carton - 2500 IU - afstyla 23
Product Label Images
The following 23 images provide visual information about the product associated with Afstyla Antihemophilic Factor (recombinant), Single Chain NDC 69911-476 by Csl Behring Lengnau Ag, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - Kit Carton - 250 IU - afstyla 17

This is a product description for AFSTYLA, a recombinant antihemophilic factor manufactured by CSL Behring. The product comes in powdered form and is administered intravenously. The text includes information regarding the product's manufacturing and distribution, as well as storage and dosage instructions.*
PRINCIPAL DISPLAY PANEL - Kit Carton - 500 IU - afstyla 18

Not available. The text seems to be a mix of random characters and words that do not make sense.*
PRINCIPAL DISPLAY PANEL - Kit Carton - 2000 IU - afstyla 20

This seems to be a description of the packaging and storage instructions for a medication called AFSTYLA, which is used as a treatment for hemophilia. The text includes information about the manufacturer, distributor, and contents of the medication, including dosage and administration instructions, expiration dates, and storage requirements. There are also some reference numbers and codes included.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.